IP Library › Granted Patent US 12691083
Granted Patent B2
US 12691083 · App. 18/684,828 · Granted Jul 28, 2026

Pharmaceutical composition for preventing or treating attention deficit/hyperactivity disorder, containing KDS2010 as active ingredient

Inventors: Bo-Eun Yoon (Yongin-si, KR); Ki Duk Park (Seoul, KR); Jong-Hyun Park (Seoul, KR)
Assignee: DANKOOK UNIVERSITY CHEONAN CAMPUS INDUSTRY ACADEMIC COOPERATION FOUNDATION
A61K31/165A61P25/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12691083
App. No.
18/684,828
Granted
Jul 28, 2026
Kind
B2
Abstract

The present invention relates to a pharmaceutical composition for preventing or treating attention deficit/hyperactivity disorder (ADHD), containing KDS2010 as an active ingredient, wherein it has been identified, in a Git1 gene-deficient hetero (+/−) mouse, that the amount of GABA is increased in the striatum of the brain, which is in charge of hyperactivity, and thus the mouse can be used as an animal model of ADHD, and it has been identified that inattention and hyperactivity are alleviated upon the administration of KDS2010 to the Git1 gene-deficient hetero (+/−) mouse, and thus KDS2010 is provided as an agent for treating ADHD.

Claims (8)

1 . A method of preventing or treating attention deficit/hyperactivity disorder (ADHD), comprising:

administering a pharmaceutical composition comprising KDS2010 or a pharmaceutically acceptable salt thereof as an active ingredient to a subject.

2 . The method of claim 1 , wherein the KDS2010 is a compound represented by the following Chemical Formula 1:

3 . The method of claim 1 , wherein the KDS2010 ameliorates concentration deficit and hyperactivity.

4 . The method of claim 1 , wherein the pharmaceutical composition comprises, for formulation, any one or more carriers selected from the group consisting of lactose, dextrose, sucrose, sorbitol, mannitol, starch, gum acacia, calcium phosphate, alginate, gelatin, calcium silicate, microcrystalline cellulose, polyvinylpyrrolidone, cellulose, water, syrup, methyl cellulose, methyl hydroxybenzoate, propyl hydroxybenzoate, talc, magnesium stearate, and mineral oil.

5 . A method of preventing or improving attention deficit/hyperactivity disorder (ADHD), comprising:

administering a health functional food composition comprising KDS2010 and a foodologically acceptable food supplemental additive to a subject.

6 . The method of claim 5 , wherein the KDS2010 is a compound represented by the following Chemical Formula 1: